52 results
8-K
EX-99.1
LUMO
Lumos Pharma Inc
7 Mar 24
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
4:44pm
clinical and regulatory strategy and will continue to oversee medical affairs as the Company prepares to initiate a pivotal Phase 3 trial evaluating
8-K
EX-99.1
LUMO
Lumos Pharma Inc
4 Jan 24
Regulation FD Disclosure
4:34pm
. Pitukcheewanont will provide his leadership in Lumos Pharma's efforts to hone its clinical and regulatory strategy, and he will continue to oversee
8-K
EX-99.1
LUMO
Lumos Pharma Inc
28 Jun 23
Lumos Pharma Announces Departure of Chief Medical Officer
4:26pm
, will oversee all clinical activities and related functions until a CMO search is complete.
“We thank David for his many contributions to Lumos Pharma
8-K/A
EX-10.6
s9sm7x87hga5o
1 Jun 20
Other Events
12:00am
8-K/A
m8q70rwbf efk7
1 Jun 20
Other Events
12:00am
DEFR14A
61bw synrd7
13 Feb 20
Revised proxy
4:37pm
DEFM14A
tabyj9iqdiywgb0
10 Feb 20
Proxy related to merger
8:30am
PRER14A
64nrjaonob90snnt1j5
9 Jan 20
Preliminary revised proxy
8:02am